These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7656857)

  • 21. Hepatitis B virus superinfection in a patient with chronic hepatitis C receiving alpha-interferon treatment.
    Teuber G; Dienes HP; Meyer zum Büschenfelde KH; Gerken G
    Hepatogastroenterology; 1995 Apr; 42(2):189-91. PubMed ID: 7672771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cryoglobulinemia in chronic hepatitis C. Improvement by alpha-interferon is independent of virus elimination].
    Glück T; Dürk H; Kötter I; Zimmermann C; Saal JG
    Med Klin (Munich); 1995 Dec; 90(12):674-80. PubMed ID: 8583982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Re-treatment with interferon-alpha in chronic hepatitis B and C virus infection].
    Teuber G; Dienes HP; Meyer zum Büschenfelde KH; Gerken G
    Z Gastroenterol; 1995 Feb; 33(2):94-8. PubMed ID: 7725763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Essential mixed cryoglobulinemia (EMC) in a case of chronic hepatitis C--successful treatment with interferon alpha.
    Pingel S; Hartmann H; Ramadori G
    Z Gastroenterol; 1994 Oct; 32(10):584-8. PubMed ID: 7716994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mixed cryoglobulinemia and chronic hepatitis C. Treatment with interferon].
    Sobrino J; Torres M; Rodríguez E; Titó L
    Med Clin (Barc); 1993 May; 100(20):799. PubMed ID: 8321064
    [No Abstract]   [Full Text] [Related]  

  • 26. alpha-Interferon retreatment of patients with chronic hepatitis C.
    Rabinovitz M; Block G; Finkelstein SD
    Am J Gastroenterol; 1996 Aug; 91(8):1523-6. PubMed ID: 8759654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. alpha-Interferon therapy for hepatitis C virus chronic infection with mixed cryoglobulinemia.
    Castilla A; Castilla I; Prieto J
    Am J Gastroenterol; 1993 Mar; 88(3):466-7. PubMed ID: 8438868
    [No Abstract]   [Full Text] [Related]  

  • 28. Prospective comparison of four lymphoblastoid interferon alpha schedules for chronic hepatitis C. A multivariate analysis of factors predictive of sustained response to treatment.
    Bellobuono A; Mondazzi L; Tempini S; Silini E; Idéo G
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1169-77. PubMed ID: 9471022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Eruptive mucocutaneous lichen planus during treatment of chronic hepatitis C with interferon alpha].
    Sassigneux P; Michel P; Joly P; Colin R
    Gastroenterol Clin Biol; 1993; 17(10):764. PubMed ID: 8288088
    [No Abstract]   [Full Text] [Related]  

  • 30. Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C.
    Ueno T; Inuzuka S; Sata M; Koh H; Tamaki S; Kin M; Sugawara H; Sakata R; Torimura T; Tanikawa K
    Hepatogastroenterology; 1995; 42(5):522-7. PubMed ID: 8751209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C. Understanding the issues.
    Miller SK
    Adv Nurse Pract; 2000 Dec; 8(12):49-50, 87-8. PubMed ID: 12397910
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of the long-term effects of treatment with oral and parenteral interferon alpha in chronic viral hepatitis patients.
    Zielińska W; Korczak-Rogoń A; Paszkiewicz J; Kowalik M; Cummins JM; Georgiades JA
    Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):359-66. PubMed ID: 9017152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cost-effectiveness analysis of the treatment of chronic hepatitis C].
    Joliot E; Vanlemmens C; Kerleau M; Le Gales C; Woronoff-Lemsi MC; Flori YA; Seror V; Hrusovsky S; Monnet E; Bresson-Hadni S; Miguet JP
    Gastroenterol Clin Biol; 1996; 20(11):958-67. PubMed ID: 9119185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnosis and treatment of viral hepatitis C].
    Bogomolov BP; Kostiunina MK
    Klin Med (Mosk); 1997; 75(9):62-4. PubMed ID: 9432548
    [No Abstract]   [Full Text] [Related]  

  • 35. [Interferon-alpha and development of psoriatic arthropathy].
    Piqueras Alcol B; de Diego Lorenzo A; Pérez Roldán F; Baños Díaz E; Clemente Ricote G
    An Med Interna; 1996 Oct; 13(10):512-3. PubMed ID: 9019204
    [No Abstract]   [Full Text] [Related]  

  • 36. Changes in serum fibrogenesis markers during interferon therapy for chronic hepatitis type C.
    Ishibashi K; Kashiwagi T; Ito A; Tanaka Y; Nagasawa M; Toyama T; Ozaki S; Naito M; Azuma M
    Hepatology; 1996 Jul; 24(1):27-31. PubMed ID: 8707274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical use of interferons in hepatology.
    Civeira MP
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():33-4. PubMed ID: 8899691
    [No Abstract]   [Full Text] [Related]  

  • 38. [Chronic hepatitis. Differential diagnosis and therapy. 2: Differential hepatitis C diagnosis].
    Schlaak JF; Gerken G
    Fortschr Med; 1997 Jul; 115(20-21):38-9. PubMed ID: 9333584
    [No Abstract]   [Full Text] [Related]  

  • 39. [Therapy of chronic hepatitis B, C and D with alpha-interferon].
    Niederau C
    Fortschr Med; 1993 Feb; 111(6):35-7. PubMed ID: 8462911
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hepatitis C--clinical aspects, diagnosis and therapy].
    Mörl M
    Fortschr Med; 1997 Jan; 115(3):26-9. PubMed ID: 9102384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.